However, there was an association between MDA levels clinical outcomes with p = 0.023 and relative risk (RR) of 1.983 (95 % CI 1.054-3.732). There were not statistically significant differences between age, GCS, bleeding volume, and MDA with clinical outcomes (p>0.06). The results of the study analysis showed that subjects who had MDA levels >494.95 ng/mL with poor mRS were 17 subjects (73.9 %), higher than those with good mRS, 3 subjects (27.3 %). Results: In 34 study subjects, 23 subjects with poor mRS and 11 subjects with good mRS were obtained. The study subjects were blood drawn for the examination of MDA levels at hospital admission, and the examination of clinical outcomes was assessed using the mRS when the patient was discharged from the hospital. Soetomo General Hospital Surabaya, Indonesia. Methods: A cohort study was enrolled in patients with intracerebral hemorrhagic stroke in Dr. This study aimed to determine the association between malondialdehyde (MDA) levels with clinical outcomes assessed using the modified Rankin Scale (mRS) in patients with acute intracerebral hemorrhagic stroke. Conclusion: There was a significant association between MDA levels and clinical outcomes assessed using the mRS in patients with acute intracerebral hemorrhagic stroke.Ībstract = "Background: Oxidative stress plays an important role in secondary brain injury after a stroke of intracerebral hemorrhage. Background: Oxidative stress plays an important role in secondary brain injury after a stroke of intracerebral hemorrhage.
0 Comments
Leave a Reply. |